Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction

被引：10
作者：
Ueland, Thor [1 ,2 ,12 ]
Kleveland, Ola [9 ,10 ]
Michelsen, Annika E. [1 ,2 ]
Wiseth, Rune [9 ,10 ]
Damas, Jan Kristian [11 ]
Holven, Kirsten B. [7 ,8 ]
Aukrust, Pal [1 ,2 ,3 ,12 ]
Gullestad, Lars [2 ,4 ,5 ,6 ]
Yndestad, Arne [1 ,2 ,5 ,6 ]
Halvorsen, Bente [1 ,2 ]
机构：
[1] Natl Hosp Norway, Internal Med Res Inst, Oslo Univ Hosp, Oslo, Norway
[2] Natl Hosp Norway, Inst Clin Med, Oslo Univ Hosp, Oslo, Norway
[3] Natl Hosp Norway, Sect Clin Immunol & Infect Dis, Oslo Univ Hosp, Oslo, Norway
[4] Natl Hosp Norway, Dept Cardiol, Oslo Univ Hosp, Oslo, Norway
[5] Univ Oslo, KG Jebsen Ctr Cardiac Res, Oslo, Norway
[6] Oslo Univ Hosp, Ctr Heart Failure Res, Oslo, Norway
[7] Dept Endocrinol Morbid Obes & Prevent Med, Norwegian Natl Advisory Unit Familial Hypercholes, Oslo, Norway
[8] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Fac Med, Oslo, Norway
[9] St Olavs Hosp, Clin Cardiol, Trondheim, Norway
[10] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, Trondheim, Norway
[11] Norwegian Univ Sci & Technol NTNU, Ctr Mol Inflammat Res, Dept Canc Res & Mol, Trondheim, Norway
[12] Univ Tromso, KG Jebsen TREC, Tromso, Norway
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2019年 / 274卷
关键词：
Lipoprotein(a); Acute coronary syndrome; IL-6; antagonism; Inflammation; RHEUMATOID-ARTHRITIS; RISK; PROTEINS; DISEASE;
D O I：
10.1016/j.ijcard.2018.06.093
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background: The IL-6 receptor antagonist tocilizumab has been shown to attenuate the proatherogenic lipoprotein a [Lp(a)] in rheumatoid arthritis. We evaluated if a single dose of tocilizumab reduced Lp(a) in patients with non-ST-elevation myocardial infarction (NSTEMI). Methods: Lp(a) was assessed by immunoassay (n = 117 patients) at 7 consecutive time-points between day 1 and 3 and at 3 and 6 months follow-up. Results: Tocilizumab did not affect Lp(a) at any time-point during the study and was not associated with cardiovascular risk factors. Conclusions: Short-time inhibition of IL-6 with tocilizumab in patients with NSTEMI did not influence Lp(a) levels. (c) 2018 Published by Elsevier B.V.
引用
收藏
页码：348 / 350
页数：3
相关论文
共 50 条
  • [21] IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
    Orrem, Hilde L.
    Nilsson, Per H.
    Pischke, Soren E.
    Kleveland, Ola
    Yndestad, Arne
    Ekholt, Karin
    Damas, Jan K.
    Espevik, Terje
    Bendz, Bjorn
    Halvorsen, Bente
    Gregersen, Ida
    Wiseth, Rune
    Andersen, Geir O.
    Ueland, Thor
    Gullestad, Lars
    Aukrust, Pal
    Barratt-Due, Andreas
    Mollnes, Tom E.
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [22] Circulating Interleukin-6 correlates with Left Ventricular Ejection Fraction in ST-Segment Elevation Myocardial Infarction
    Samalo, D.
    Fadil, M.
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0F) : F4 - F4
  • [23] Non-ST-Elevation Acute Myocardial Infarction With Normal Coronary Arteries: Predictors and Prognosis
    Cortell, Alejandro
    Sanchis, Juan
    Bodi, Vicente
    Nunez, Julio
    Mainar, Luis
    Pellicer, Mauricio
    Minana, Gema
    Santas, Enrique
    Dominguez, Eloy
    Palau, Patricia
    Llacer, Angel
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2009, 62 (11): : 1260 - 1266
  • [24] Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction
    Bennet, AM
    Prince, JA
    Fei, GZ
    Lyrenäs, L
    Huang, YH
    Wiman, B
    Frostegård, J
    de Faire, U
    [J]. ATHEROSCLEROSIS, 2003, 171 (02) : 359 - 367
  • [25] Patterns of statin prescription in acute myocardial infarction The French registry of Acute ST-elevation or non-ST-elevation Myocardial Infarction (FAST-MI)
    Ferrieres, Jean
    Bataille, Vincent
    Leclercq, Florence
    Geslin, Philippe
    Ruidavets, Jean-Bernard
    Grollier, Gilles
    Bernard, Paul
    Cambou, Jean-Pierre
    Simon, Tabassome
    Danchin, Nicolas
    [J]. ATHEROSCLEROSIS, 2009, 204 (02) : 491 - 496
  • [26] The effect of serum uric acid levels on the long-term prognosis of patients with non-ST-elevation myocardial infarction
    Kuzma, Lukasz
    Kulikowska, Agata
    Kurasz, Anna
    Niwinska, Marta Maria
    Zalewska-Adamiec, Malgorzata
    Dobrzycki, Slawomir
    Bachorzewska-Gajewska, Hanna
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (11): : 1255 - 1263
  • [27] Clinical Outcomes and Predictors of ST-Elevation Versus Non-ST-Elevation Myocardial Infarction with Non-Obstructive Coronary Arteries
    Xu, Bin
    Abdu, Fuad A.
    Liu, Lu
    Mohammed, Abdul-Quddus
    Yin, Guoqing
    Luo, Yanru
    Xu, Siling
    Lv, Xian
    Fan, Rui
    Che, Wenliang
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2020, 360 (06) : 686 - 692
  • [28] Non-ST-Elevation Myocardial Infarction with Non-significant Coronary Artery Disease as a Symptom of Occult or New Malignancy
    Kobo, Ofer M.
    Evgrafov, Elit Vainer
    Cohen, Yuval
    Lerner, Yael
    Khatib, Alaa
    Hoffman, Ron
    Roguin, Ariel
    Tzoran, Inna
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2019, 21 (06): : 381 - 385
  • [29] Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction
    Groot, Hilde E.
    Al Ali, Lawien
    van Der Horst, Iwan C. C.
    Schurer, Remco A. J.
    van Der Werf, L. Hindrik W.
    Lipsic, Erik
    van Veldhuisen, Dirk J.
    Karper, Jacco C.
    van Der Harst, Pim
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2019, 108 (06) : 612 - 621
  • [30] Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-SegmentElevation Myocardial Infarction Employing the SOMAscan Proteomics Platform
    George, Marc J.
    Kleveland, Ola
    Garcia-Hernandez, Jorge
    Palmen, Jutta
    Lovering, Ruth
    Wiseth, Rune
    Aukrust, Pal
    Engmann, Jorgen
    Damas, Jan Kristian
    Hingorani, Aroon D.
    Gullestad, Lars
    Casas, Juan P.
    Ueland, Thor
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (12):
12345